{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:42:35Z","timestamp":1790206955509,"version":"4.1.0"},"reference-count":36,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1136\/jnnp-2015-310907","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T03:10:20Z","timestamp":1442977820000},"page":"620-627","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":59,"title":["A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK"],"prefix":"10.1136","volume":"87","author":[{"given":"A S","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Pelayo-Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M RB","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Laur\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Stancanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D","family":"Wechalekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Gillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P N","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,8,4]]},"reference":[{"key":"key-10.1136\/jnnp-2015-310907-1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2015-310907-2","doi-asserted-by":"crossref","first-page":"27207","DOI":"10.1074\/jbc.M101024200","article-title":"Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants","volume":"276","author":"Quintas","year":"2001","journal-title":"J Biol Chem"},{"key":"key-10.1136\/jnnp-2015-310907-3","first-page":"282","article-title":"Liver transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative?","volume":"21","author":"Ericzon","year":"2015","journal-title":"Liver Transpl"},{"key":"key-10.1136\/jnnp-2015-310907-4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/brain\/123.7.1495","article-title":"The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation","volume":"123","author":"Adams","year":"2000","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2015-310907-5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/WNL.0b013e3181ea15d4","article-title":"Progression of transthyretin amyloid neuropathy after liver transplantation","volume":"75","author":"Liepnieks","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2015-310907-6","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1007\/s00415-013-7051-7","article-title":"Long-term effects of tafamidis for the treatment of transthyretin familial polyneuropathy","volume":"260","author":"Coelho","year":"2013","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2015-310907-7","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"key-10.1136\/jnnp-2015-310907-8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11910-013-0435-3","article-title":"FAP neuropathy and emerging treatments","volume":"14","author":"Adams","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key-10.1136\/jnnp-2015-310907-9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2015-310907-10","first-page":"P88","article-title":"Forty years experience with type 1 amyloid neuropathy","volume-title":"Amyloid and amyloidosis","author":"Coutinho","year":"1980"},{"key":"key-10.1136\/jnnp-2015-310907-11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000154146","article-title":"Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence","volume":"43","author":"Sousa","year":"1993","journal-title":"Hum Hered"},{"key":"key-10.1136\/jnnp-2015-310907-12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ajmg.1320600606","article-title":"Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type 1 in Povoa do Varzim and Vila do Condo (North Portugal)","volume":"60","author":"Sousa","year":"1995","journal-title":"Am J Med Genet"},{"key":"key-10.1136\/jnnp-2015-310907-13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2008.02.019","article-title":"Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus","volume":"270","author":"Kato-Motozaki","year":"2008","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2015-310907-14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","article-title":"Tabulation of human tranthyretin (TTR) variants, 2003","volume":"10","author":"Connors","year":"2003","journal-title":"Amyloid"},{"key":"key-10.1136\/jnnp-2015-310907-15","unstructured":"http:\/\/amyloidosismutations.com\/mut-attr.php. May 2015."},{"key":"key-10.1136\/jnnp-2015-310907-16","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/eurheartj\/ehr383","article-title":"Cardiac phenotype and clinical outcomes of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant","volume":"33","author":"Sattianayagam","year":"2012","journal-title":"Eur Heart J"},{"key":"key-10.1136\/jnnp-2015-310907-17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1172\/JCI112573","article-title":"Biocheminal and molecular genetic characterisation of a new variant prealbumin associated with hereditary amyloidosis","volume":"78","author":"Wallace","year":"1986","journal-title":"J Clin Invest"},{"key":"key-10.1136\/jnnp-2015-310907-18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/brain\/110.5.1231","article-title":"Hereditary amyloid polyneuropathy in north west Ireland","volume":"110","author":"Staunton","year":"1987","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2015-310907-19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/jnnp.59.1.45","article-title":"Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study","volume":"59","author":"Reilly","year":"1995b","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2015-310907-20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/13506120209072442","article-title":"Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy","volume":"9","author":"Kotani","year":"2002","journal-title":"Amyloid"},{"issue":"(Pt 4)","key":"key-10.1136\/jnnp-2015-310907-21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/brain\/118.4.849","article-title":"Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy","volume":"118","author":"Reilly","year":"1995","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2015-310907-22","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1007\/s00415-013-7124-7","article-title":"Diagnostic Hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy","volume":"260","author":"Dohrn","year":"2013","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2015-310907-23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1212\/WNL.0b013e3181ec7fda","article-title":"Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser","volume":"75","author":"Yang","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2015-310907-24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/13506129.2013.827110","article-title":"Description of tranthyretin S50A, S52P and G47A mutation in familial amyloidosis polyneuropathy","volume":"20","author":"Gonzalez-Duarte","year":"2013","journal-title":"Amyloid"},{"key":"key-10.1136\/jnnp-2015-310907-25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Synposium on Amyloid and Amyloidosis","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"key":"key-10.1136\/jnnp-2015-310907-26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11916-011-0181-7","article-title":"Diagnosis and Treatment of Pain in small fibre neuropathy","volume":"15","author":"Hovaguimian","year":"2011","journal-title":"Curr Pain Headache Rep"},{"key":"key-10.1136\/jnnp-2015-310907-27","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1212\/WNL.43.11.2406","article-title":"Practice parameter for carpal tunnel syndrome (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"43","year":"1993","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2015-310907-28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1529-8027.2011.00350.x","article-title":"Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease","volume":"16","author":"Murphy","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"key-10.1136\/jnnp-2015-310907-29","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/ene.12225","article-title":"Effect on disability and safety of tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy","volume":"20","author":"Lozeron","year":"2013","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2015-310907-30","volume-title":"New principles of best practice in clinical audit","author":"Burgess","year":"2011","edition":"2"},{"key":"key-10.1136\/jnnp-2015-310907-31","first-page":"P160","article-title":"Congo red overlay aids classification of amyloid deposits","volume-title":"Amyloid and amyloidosis. 1998","author":"Tennent","year":"1999"},{"key":"key-10.1136\/jnnp-2015-310907-32","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.91.4.962","article-title":"A novel variant of thansthyretin, 59Thr-Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family","volume":"91","author":"Booth","year":"1995","journal-title":"Circulation"},{"key":"key-10.1136\/jnnp-2015-310907-33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.nmd.2015.02.001","article-title":"Yransthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy","volume":"25","author":"Carr","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"key-10.1136\/jnnp-2015-310907-34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/13506129.2013.845745","article-title":"Genotype, echocardiography, and survival in familial transthyretin amyloidosis","volume":"20","author":"Arruda-Olsen","year":"2013","journal-title":"Amyloid"},{"key":"key-10.1136\/jnnp-2015-310907-35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bjh.12286","article-title":"Systemic amyloidosis in England: an epidemiological study","volume":"161","author":"Pinney","year":"2013","journal-title":"Brit J Haem"},{"key":"key-10.1136\/jnnp-2015-310907-36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/13506129.2011.565524","article-title":"Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis","volume":"18","author":"Koike","year":"2011","journal-title":"Amyloid"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2015-310907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:00:50Z","timestamp":1601056850000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2015-310907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,4]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,5,13]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1136\/jnnp-2015-310907"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2015-310907","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,4]]}}}